更年期荷尔蒙疗法和冠心病:过山车的历史
M Nudy1,2, J Buerger3, S Dreibelbis3
1Division of Cardiology, Heart and Vascular Institute, Penn State Hershey Medical Center, Hershey, PA, USA.
Climacteric : the journal of the International Menopause Society
|December 6, 2023
概括
更年期激素疗法 (HT) 在更年轻的女性中对心血管健康是安全的,在更年期后不久开始治疗. 早期使用HT可能会带来好处,与之前的担忧相反,与适合候选人的当前建议保持一致.
科学领域:
- 心血管科学 心血管科学
- 妇女健康 妇女健康
- 内分泌学 在内分泌学.
背景情况:
- 冠心病 (CHD) 是绝经后妇女死亡的主要原因.
- 更年期激素治疗 (HT) 有效地管理更年期症状,但其心血管影响仍在争论中.
- 包括HERS和WHI在内的相互矛盾的研究结果导致了关于HT和CHD风险的混乱.
研究的目的:
- 审查更年期后女性冠心病 (CHD) 相关的更年期激素治疗 (HT) 使用的历史背景.
- 评估证据支持HT的潜在心脏病益处,特别是当在更年期早期开始时.
- 为适当选择的年轻的绝经后妇女提供HT心血管安全的保证.
主要方法:
- 对更年期荷尔蒙疗法 (HT) 和冠状动脉心脏病 (CHD) 风险的观察,回顾和临床试验数据的审查.
- 对"定时假说"的分析,表明早期HT发起的绝经后对心血管有好处.
- 综合当前的证据,以提供关于HT使用的共识建议的信息.
主要成果:
- 早期的研究表明,使用HT可以改善心血管疾病的益处和生存率.
- 在HERS和WHI研究引入了关于HT的心血管安全的不确定性.
- "时机假设"提出,在更年期开始后不久开始HT可能会给心血管带来好处.
结论:
- 从心血管的角度来看,HT在适当选择的年轻的绝经后妇女中使用时可能是安全的.
- 有证据表明,当HT早期启动时,可能会对心血管有好处,这与"时机假设"一致.
- 目前的共识支持基于时间和个体风险因素在特定人群中明智使用HT.
相关概念视频
Menopause
171
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
171
Hormonal Regulation of the Menstrual Cycle
403
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
403
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Psychoneuroimmunology: Cardiovascular Disease
31
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
31


